Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-α but Not Observation in Intermediate Risk Melanoma Patients

BACKGROUND: E1697 was a phase III trial of adjuvant interferon (IFN)-α2b for one month (Arm B) versus observation (Arm A) in patients with resected melanoma at intermediate risk. We evaluated the levels of candidate serum cytokines, the HLA genotype, polymorphisms of CTLA4 and FOXP3 genes and the de...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarhini, Ahmad A., Lin, Yan, Zahoor, Haris, Shuai, Yongli, Butterfield, Lisa H., Ringquist, Steven, Gogas, Helen, Sander, Cindy, Lee, Sandra, Agarwala, Sanjiv S., Kirwood, John M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508028/
https://www.ncbi.nlm.nih.gov/pubmed/26192408
http://dx.doi.org/10.1371/journal.pone.0132745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508028/
https://www.ncbi.nlm.nih.gov/pubmed/26192408
http://dx.doi.org/10.1371/journal.pone.0132745

Ejemplares similares